These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20193818)

  • 1. Relief of chronic neuropathic pain through endothelin antagonism.
    Murphy DM; O'Callaghan DS; Gaine SP
    Am J Med; 2010 Mar; 123(3):e7. PubMed ID: 20193818
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic selective endothelin A receptor antagonism reduces serum uric acid in hypertensive chronic kidney disease.
    Dhaun N; Johnston NR; Goddard J; Webb DJ
    Hypertension; 2011 Aug; 58(2):e11-2. PubMed ID: 21709210
    [No Abstract]   [Full Text] [Related]  

  • 3. Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects.
    Mehta PK; Simpson L; Lee EK; Lyle TA; McConnell ME; Book WM
    Tex Heart Inst J; 2008; 35(3):256-61. PubMed ID: 18941642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice.
    Benbouzid M; Choucair-Jaafar N; Yalcin I; Waltisperger E; Muller A; Freund-Mercier MJ; Barrot M
    Eur J Pain; 2008 Nov; 12(8):1008-17. PubMed ID: 18331804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective and mixed endothelin receptor antagonism in cardiovascular disease.
    Dhaun N; Pollock DM; Goddard J; Webb DJ
    Trends Pharmacol Sci; 2007 Nov; 28(11):573-9. PubMed ID: 17950470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease.
    Girgis RE; Frost AE; Hill NS; Horn EM; Langleben D; McLaughlin VV; Oudiz RJ; Robbins IM; Seibold JR; Shapiro S; Tapson VF; Barst RJ
    Ann Rheum Dis; 2007 Nov; 66(11):1467-72. PubMed ID: 17472992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic renoprotection: are the stars finally moving into alignment?
    Stafford-Smith M
    Crit Care Med; 2011 Apr; 39(4):906-7. PubMed ID: 21613849
    [No Abstract]   [Full Text] [Related]  

  • 8. [Updated treatment of primary pulmonary hypertension -- the role of endothelin receptor antagonists].
    Callejas Rubio JL; Ortego Centeno N; Navarro Pelayo F; Vallejo Rodríguez I
    Farm Hosp; 2004; 28(4):294-5. PubMed ID: 15369441
    [No Abstract]   [Full Text] [Related]  

  • 9. Endothelin receptor antagonists-induced hepatotoxicity.
    Macías Saint-Gerons D; de la Fuente Honrubia C; Montero D; Catalá-López F
    Intern Med J; 2013 May; 43(5):609-10. PubMed ID: 23668280
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective or nonselective endothelin receptor blockade in pulmonary arterial hypertension.
    Wilkins MR
    Am J Respir Crit Care Med; 2004 Feb; 169(4):433-4. PubMed ID: 14766656
    [No Abstract]   [Full Text] [Related]  

  • 11. Dual ET(A)/ET(B) vs. selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension.
    Opitz CF; Ewert R
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():1-9. PubMed ID: 16919004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endothelin-receptor antagonists in therapy of pulmonary arterial hypertension].
    Ghofrani HA
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S177-8. PubMed ID: 19718611
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-L-cysteine in rats.
    Naik AK; Tandan SK; Dudhgaonkar SP; Jadhav SH; Kataria M; Prakash VR; Kumar D
    Eur J Pain; 2006 Oct; 10(7):573-9. PubMed ID: 16214382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sitaxsentan (ICOS-Texas Biotechnology).
    Wu-Wong JR
    Curr Opin Investig Drugs; 2001 Apr; 2(4):531-6. PubMed ID: 11566012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin receptor antagonists in pulmonary arterial hypertension.
    Dupuis J; Hoeper MM
    Eur Respir J; 2008 Feb; 31(2):407-15. PubMed ID: 18238950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin receptor antagonism and renin inhibition as treatment options for scleroderma kidney.
    Dhaun N; MacIntyre IM; Bellamy CO; Kluth DC
    Am J Kidney Dis; 2009 Oct; 54(4):726-31. PubMed ID: 19376621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A in experimental neuropathic pain.
    Bach-Rojecky L; Relja M; Lacković Z
    J Neural Transm (Vienna); 2005 Feb; 112(2):215-9. PubMed ID: 15657640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous melatonin abolishes mechanical allodynia but not thermal hyperalgesia in neuropathic pain. The role of the opioid system and benzodiazepine-gabaergic mechanism.
    Zurowski D; Nowak L; Machowska A; Wordliczek J; Thor PJ
    J Physiol Pharmacol; 2012 Dec; 63(6):641-7. PubMed ID: 23388480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genistein, a natural phytoestrogen from soy, relieves neuropathic pain following chronic constriction sciatic nerve injury in mice: anti-inflammatory and antioxidant activity.
    Valsecchi AE; Franchi S; Panerai AE; Sacerdote P; Trovato AE; Colleoni M
    J Neurochem; 2008 Oct; 107(1):230-40. PubMed ID: 18691380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases.
    Humbert M; Simonneau G
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):93-101. PubMed ID: 16932638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.